hnbadger1
7 minutes ago
Grok 3 (Deepsearch) gives us a 70% chance of approval by EMA in
2025.
“ Conclusion
In conclusion, blarcamesine has a strong case for EMA approval in 2025, with a 70% estimated probability, driven by significant cognitive benefits, supportive biomarker data, and a favorable safet